ARCA biopharma Stock Price, News & Analysis
Company Description
ARCA biopharma (NASDAQ: ABIO) is a publicly traded pharmaceutical preparation manufacturing company in the In Vitro & in Vivo Diagnostic Substances sector. The company has a market capitalization of $34.8M, ranking #5,845 among all listed U.S. companies by market cap.
ABIO stock has declined 100.0% over the past year. Shares last traded at $2.40.
This page provides a comprehensive overview of ABIO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ARCA biopharma (ABIO) stock last traded at $2.40. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $34.8M, ABIO is classified as a micro-cap stock with approximately 14.5M shares outstanding.
Latest News
ARCA biopharma has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include stock split, acquisition, dividends, earnings. View all ABIO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ABIO Company Profile & Sector Positioning
ARCA biopharma (ABIO) operates in the Pharmaceutical Preparation Manufacturing industry within the broader In Vitro & in Vivo Diagnostic Substances sector and is listed on the NASDAQ.